chrisvoncsefalvay/vaers-outcomes huggingface dataset:
13 days following the first booster, had pain in left chest beginning sporadically around approximately 3pm.  By 6pm the pain was continuous.  It felt like a charley horse or electrical shock in my heart. I went to an ER. The last thing I remember was being given morphine. I was hospitalized until Monday November 22nd. I underwent numerous tests including a stress test and GI related tests. All results were inconclusive.  An electrophysiologist recommended implanting a loop recorder.  I chose to do this on an outpatient basis.  Had the procedure done on February.  Had the device explanted a week later because the incision opened and the device began backing itself out of the open incision area.  Am now recording my symptoms with the Kardiamobile device and patiently waiting for someone to figure out the solution to the ongoing cardiac symptoms I?m experiencing since (probably) having Covid.
Pt received Immunizations on 7/18/05 came in today 7/20/05 with redness and swelling in left thigh.
Almost had a heart attack from COVID-19 Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Almost had a heart attack from COVID-19 Vaccine) in an elderly patient of an unknown gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    There was no reported medical history.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram every two weeks. On an unknown date, the patient experienced FEELING ABNORMAL (Almost had a heart attack from COVID-19 Vaccine). At the time of the report, FEELING ABNORMAL (Almost had a heart attack from COVID-19 Vaccine) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       Concomitant medication was not reported.  Therapy date and duration of Moderna COVID-19 vaccine was unknown. The daily dose of Humira was given as citrate free (4-2) (1 in 1 once). Therapy duration and date of Humira was unknown. It was reported that the health care professional gave patient's pen to other patient's of the HCP with Humira (40 mg/0.4ml) (40 milligram, solution for injection in pre-filled pen.)- Drug prescribing error.  The causality for the event of Almost had a heart attack from COVID-19 Vaccine with Humira was not reported. It was unknown if the patient was enrolled in COVID-19 vaccine trial.  Treatment information was not provided.
Vaccine site reaction - 15 x 15 cm area of induration, warmth, and erythema.
14hrs of severe muscle pain, chills, fever, headache, nausea, vomiting; unable to get out of bed or hold down fluids; practically delirious; close to needing IV fluids.
Arm became extremely inflamed, hot to the touch, and very hard. It was also very itchy.
swollen arm; chills; swollen arm that hurt; vaccine radiated to her neck; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm), PAIN IN EXTREMITY (swollen arm that hurt), UNEVALUABLE EVENT (vaccine radiated to her neck) and CHILLS (chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and LISINOPRIL for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (swollen arm that hurt) and UNEVALUABLE EVENT (vaccine radiated to her neck). On 03-Feb-2021, the patient experienced PERIPHERAL SWELLING (swollen arm) and CHILLS (chills). On 03-Feb-2021, PERIPHERAL SWELLING (swollen arm) and CHILLS (chills) had resolved. On 09-Feb-2021, PAIN IN EXTREMITY (swollen arm that hurt) had resolved. On 09-Mar-2021, UNEVALUABLE EVENT (vaccine radiated to her neck) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   This case was linked to MOD-2021-058661 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Followup information was received and  contains no significant information
I started a low grade fever around 7th of June, I contacted my doctor because I believe I had a prostate problem.  He prescribed a antibiotic which was Ciprofloxacin 500mg 2xday for 10 days to take.   I am not sure if it is related to the vaccine.
pt recvd vax on 23nov94; felt ill by next day; to hosp   28nov94 w/ leg paralysis; pt dx w/ idiopathic transverse myelitis of the spine;as of 1dec94 sxs improved but remained hosp;
NUMBNESS IN BOTH ARMS; TINGLING IN ARM; PAIN IN RIGHT ARM ALL THE WAY TO THE WRIST; INJECTION SITE SORE; HEADACHE; This spontaneous report received from a patient concerned a 55 year old male. The patient's height, and weight were not reported. The patient's past medical history included car accident, and concurrent conditions included cataract, teeth problems, nerve condition, penicillin allergy, marijuana abuse, non-alcohol user, and cigarette smoker. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 203A21A expiry: UNKNOWN) dose was not reported, administered on 27-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 27-MAY-2021, the subject experienced headache. On 30-MAY-2021, the subject experienced numbness in both arms. On 30-MAY-2021, the subject experienced tingling in arm. On 30-MAY-2021, the subject experienced pain in right arm all the way to the wrist. On 30-MAY-2021, the subject experienced injection site sore. The action taken with covid-19 vaccine  was not applicable. The patient recovered from headache on MAY-2021, had not recovered from pain in right arm all the way to the wrist, tingling in arm, and numbness in both arms, and the outcome of injection site sore was not reported. This report was non-serious.
hard, red, swollen, hot, painful Left arm - area about 1 1/2" x 2 1/2" at injection site pain in left lymph node area- under arm
On 06/28/2021 I had a fever of 104, headache, rash on arm, achy all over, and fatigue. Fever was 2-3 hours, everything else lasted just about two days.
Abnormally sore left arm the day following the injection.   Lightheaded with runny nose and scratchy throat the day following the injection.  Unusual joint aches / pain the day following the injection.
sleepy; tiredness; weakness; fluish; This case was reported by a consumer via call center representative and described the occurrence of sleepiness in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10th October 2019, the patient received the 1st dose of Shingrix. In October 2019, less than a week after receiving Shingrix, the patient experienced sleepiness, tiredness, weakness and flushing. On an unknown date, the outcome of the sleepiness, tiredness, weakness and flushing were unknown.   It was unknown if the reporter considered the sleepiness, tiredness, weakness and flushing to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient was sleepy, tired, weak, fluish after receiving Shingrix.  The patient asked how long do the side effects of the Shingrix shot last. The pharmacist stated that the majority of solicited local adverse reactions and general adverse events seen with Shingrix had a median duration of 2 to 3 days. The patient asked if these symptoms were not normal. The patient asked if it was okay for to have the 2nd dose. Or could have milder symptoms the next time?
pain and hardness at the injection; itchy inflamed lump at injection site.; red; Runny nose; coughing; pain in the knee, feet and nails; headache; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red), VACCINATION SITE MASS (itchy inflamed lump at injection site.), COUGH (coughing), RHINORRHOEA (Runny nose) and HEADACHE (headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (red), VACCINATION SITE MASS (itchy inflamed lump at injection site.), COUGH (coughing), RHINORRHOEA (Runny nose), HEADACHE (headache), ARTHRALGIA (pain in the knee, feet and nails) and VACCINATION SITE PAIN (pain and hardness at the injection). At the time of the report, ERYTHEMA (red), COUGH (coughing), RHINORRHOEA (Runny nose), HEADACHE (headache) and ARTHRALGIA (pain in the knee, feet and nails) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
administer your vaccine subcutaneously instead of IM; This case was reported by a pharmacist via call center representative and described the occurrence of intramuscular formulation administered by other route in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix (subcutaneous). On an unknown date, unknown after receiving Shingrix, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated, one immunizer administered Singrix vaccine subcutaneously instead of intramuscularly to the patient, which led to intramuscular formulation administered by other route. The reporter asked if any guidance was helpful, they were wondering if any harm was done and if patient should be getting her second dose again just to maintain full coverage. The reporter did not have DOB (date of birth) at time of chat and stopped responding when asked for more vaccine details (date of administration, lot and expiry date). No further information was reported The reporter was unable to obtain permission for follow up.
discomfort/ discomfort below breast bone; This case was reported by a other health professional via interactive digital media and described the occurrence of sternal pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th July 2019, the patient received Shingrix. On 22nd July 2019, 4 days after receiving Shingrix, the patient experienced sternal pain. On an unknown date, the outcome of the sternal pain was unknown.   It was unknown if the reporter considered the sternal pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was captured as adult as per vaccine indication. The patient had Shingrix shot 4 days ago and the patient experienced lot of discomfort below breast bone. The patient asked if this be a reaction to the shot? The case has been linked to the cases US2019AMR135418 and US2019AMR135404, reported by same reporter.
Patient signed up for vaccination clinic with Healthcare. He answered his screening questions indicating that he had not previously received a Covid vaccination or another other vaccination in the last 14 days. However, when the pharmacy went to bill the prescription to the patients prescription insurance it was found out that the patient received their fist dose of Moderna vaccine on 3/16/21 at Pharmacy. Healthcare called Pharmacy and confirmed the dose was administered on 3/16/21.
This spontaneous case was reported by a physician and describes the occurrence of HYPOACUSIS (I now have a 20% loss of hearing in my right ear), EAR DISCOMFORT (I feel pressure), TINNITUS (I have this constant ringing in my ear), EAR DISCOMFORT (it felt like someone was shoving a marble in my ear) and VACCINATION SITE NODULE (a knot at the injection site) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE NODULE (a knot at the injection site) and VACCINATION SITE PAIN (soreness at injection site). On 16-Feb-2021, the patient experienced HYPOACUSIS (I now have a 20% loss of hearing in my right ear), EAR DISCOMFORT (I feel pressure), TINNITUS (I have this constant ringing in my ear) and EAR DISCOMFORT (it felt like someone was shoving a marble in my ear). At the time of the report, HYPOACUSIS (I now have a 20% loss of hearing in my right ear), EAR DISCOMFORT (I feel pressure), TINNITUS (I have this constant ringing in my ear) and EAR DISCOMFORT (it felt like someone was shoving a marble in my ear) had resolved and VACCINATION SITE NODULE (a knot at the injection site) and VACCINATION SITE PAIN (soreness at injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  The patient reported that he saw an ENT specialist and that he had an unrelate issue and it had since resolved. No treatment medications was reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2021: NNI On 26-Jul-2021: Updated outcome of events from unknown to resolved.
Patient called and stated had been in ICU and diagnosed with "pneumococcal pneumonia ammonia" according to patient. Described symptoms as either fainting or seizing. Patient released from hospital on 2/11/2020
Every bone in her body ached; fever; her arm has a big red round circle and is puffy and the redness is large like 2 inches diameter; itchy joints; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), VACCINATION SITE ERYTHEMA (her arm has a big red round circle and is puffy and the redness is large like 2 inches diameter), PRURITUS (itchy joints) and BONE PAIN (Every bone in her body ached) in a female patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     Question:Describe relevant medical history/conditions, allergy, concomitant diseases and risk factor.Answer:Allergic to pennicilin.  Previously administered products included for Product used for unknown indication: Flu shot and RSV. Past adverse reactions to the above products included Injection site erythema with Flu shot; and No adverse event with RSV. Concurrent medical conditions included Penicillin allergy.    On 01-Oct-2023, the patient received fifth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 01-Oct-2023, the patient experienced PYREXIA (fever), VACCINATION SITE ERYTHEMA (her arm has a big red round circle and is puffy and the redness is large like 2 inches diameter) and PRURITUS (itchy joints). On an unknown date, the patient experienced BONE PAIN (Every bone in her body ached). At the time of the report, PYREXIA (fever), VACCINATION SITE ERYTHEMA (her arm has a big red round circle and is puffy and the redness is large like 2 inches diameter) and PRURITUS (itchy joints) had not resolved and BONE PAIN (Every bone in her body ached) outcome was unknown.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication not reported.   Treatment medication not reported.  The patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. She mentioned she had minor side effects with the past Moderna vaccines. She usually gets a red arm that stays red for a long time, even with the flu shot. She received the latest Moderna vaccine this past on 01-Oct-2023. About 5-6 hours later her arm was red. She was used to that but not so soon. After 24 hours she started having fever. It bothered her. She did not have fever in 20 years. Every bone in her body ached. Her arm has a big red round circle and is puffy and the redness is large like 2 inches diameter. She was not having fever anymore, but the arm was still red and she has itchy joints.   This case was linked to US-MODERNATX, INC.-MOD-2023-743542 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-743542:Same patient, Monovalent Dose
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 56-year-old female patient who received SHINGRIX (batch number 32GR4, expiry date 4th July 2020) and (batch number D3L5G, expiry date 29th November 2020) for prophylaxis. Previously administered products included SHINGRIX (1st dose received on an unknown date). Concomitant products included ADACEL. On 3rd June 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, the 2nd dose was an unknown dose. On 4th June 2018, 1 days after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the patient experienced pharmaceutical product complaint. On an unknown date, the outcome of the injection site pain was recovered/resolved and the outcome of the pharmaceutical product complaint was unknown.  The reporter considered the injection site pain to be almost certainly related to SHINGIRX. Additional details were provided as follows: On 26th May 2018, the patient received 1st dose of ADACEL on the left arm. The patient received SHINGRIX on the left arm. The batch number of the adjuvant/liquid was D3L5G with an expiry of 11/29/2020. The pharmacist reported that he had been giving SHINGRIX injections since January 2018 and said that this last batch of SHINGRIX might be suspect. He reported that the patient experienced Adverse drug reactions (ADE's) unlike previous injections. The reporter did not have any product to return and was not seeking reimbursement. When asked, the pharmacist reported there was nothing unusual about the vials or the box. The side effect profile and percentages of ADEs experienced were reviewed. The pharmacist also reported via VAERS. This case is 1 of the 7 linked cases reported by the same reporter.
States 10/25/2004 PM, right arm became ver swollen, red, hot to touch and painful. Patient was in California was instructed to seek medical care. 10/28/04, called from California and states they are seeing also seeing adverse reactions and they were going to als report this incident.
After my first shot of Pfizer, I have been feeling short of breath, heart raising, rashes, brain fog, etc.
Arm is swollen; Redness is spreading like cellulitis; Painful; Hot to the touch; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING (Arm is swollen), ERYTHEMA (Redness is spreading like cellulitis), PAIN IN EXTREMITY (Painful) and INJECTION SITE WARMTH (Hot to the touch) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical history Information was reported.     On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced PERIPHERAL SWELLING (Arm is swollen), ERYTHEMA (Redness is spreading like cellulitis), PAIN IN EXTREMITY (Painful) and INJECTION SITE WARMTH (Hot to the touch). The patient was treated with CEFALEXIN (KEFLEX [CEFALEXIN]) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Arm is swollen), ERYTHEMA (Redness is spreading like cellulitis), PAIN IN EXTREMITY (Painful) and INJECTION SITE WARMTH (Hot to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
8 days after I was given the booster shot, I developed urticaria.  It was intense for 4 days, then slowly subsided.  I still have some mild symptoms 3 months later.
now but sometimes early in the morning when he wakes up and until he gets the temperature up in his apartment he experiences chills; temperature is in the high number and he has a little chills right now while speaking; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer, the male patient of 82-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in arm left on 01Apr2021 13:00 (Batch/lot number was not reported) (at the age of 82-years-old) as single dose for covid-19 immunisation. The patient medical history was not reported. Th patient family medical history relevant to events includes none. Concomitant medications included none. The patient did not receive any other vaccines within four weeks prior to the vaccination. History of all previous immunization with the Pfizer vaccine considered as suspect includes none. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1, administered in arm left on 11Mar2021 for covid-19 immunisation and experienced very itchy episode, chills and runny nose. On an unspecified date in Apr2021, patient stated it was not going on now but sometimes early in the morning when he wakes up and until he gets the temperature up in his apartment, he experiences chills. Patient stated if the heat was on, he does not notice chills but if the heat is not on, he does notice it. The temperature was in the high number and he has a little chill right now while speaking. The events did not require a visit to emergency room or physician office. The patient underwent lab tests and procedures which included Covid-19 antibody test which showed negative (on not exposed to virus) on an unknow date in 2021. Therapeutic measures were taken as a result of event chills included Tylenol. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Expired Twinrix administered; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 74-year-old female patient who received HAB (Twinrix adult) (batch number unknown, expiry date 1st January 2023) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Concurrent medical conditions included hypertension and renal disease.   On 17th January 2023, the patient received Twinrix adult and Twinrix Pre-Filled Syringe Device. On 17th January 2023, unknown after receiving Twinrix adult and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt date: 17-JAN-2023 Reporter comment: The patient received a dose of Twinrix that expired on 1st January 2023. Nothing else was reported. The reporter consented to follow up. Additional Supportive Information: The patient received an expired dose of Twinrix vaccine which led to expired vaccine used.